Dysregulated brain regulatory T cells fail to control reactive gliosis following repeated antigen stimulation

[1]  P. Verginis,et al.  Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle , 2021, Frontiers in Immunology.

[2]  Shuxian Hu,et al.  Dysregulated Microglial Cell Activation and Proliferation Following Repeated Antigen Stimulation , 2021, Frontiers in Cellular Neuroscience.

[3]  W. Hsueh,et al.  Low visceral adipose tissue regulatory T cells are associated with higher comorbidity severity in patients undergoing bariatric surgery , 2020, Surgical Endoscopy.

[4]  H. Gendelman,et al.  Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders , 2020, Molecular Neurodegeneration.

[5]  J. Attems,et al.  CD8+ T-cells infiltrate Alzheimer’s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice , 2020, Brain, Behavior, and Immunity.

[6]  C. Scheinecker,et al.  Treg cells in health and autoimmune diseases: New insights from single cell analysis. , 2019, Journal of autoimmunity.

[7]  Shuxian Hu,et al.  Recall Responses from Brain-Resident Memory CD8+ T Cells (bTRM) Induce Reactive Gliosis , 2019, iScience.

[8]  V. Yong,et al.  When encephalitogenic T cells collaborate with microglia in multiple sclerosis , 2019, Nature Reviews Neurology.

[9]  H. Rabb,et al.  Reparative T lymphocytes in organ injury. , 2019, The Journal of clinical investigation.

[10]  J. Lokensgard,et al.  Brain-Resident T Cells Following Viral Infection. , 2019, Viral immunology.

[11]  Osamu Yoshie,et al.  Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery , 2019, Nature.

[12]  T. Deierborg,et al.  Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response , 2018, Front. Cell. Neurosci..

[13]  Jonathan H. Esensten,et al.  Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier. , 2018, The Journal of allergy and clinical immunology.

[14]  Y. Chu,et al.  The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy , 2018, Journal of Neuroinflammation.

[15]  Feng Xu,et al.  CD8+ Resident Memory T Cells and Viral Infection , 2018, Front. Immunol..

[16]  C. Leslie,et al.  Memory of Inflammation in Regulatory T Cells , 2016, Cell.

[17]  M. Pellegrini,et al.  An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells , 2016, Nature Medicine.

[18]  C. Kleinschnitz,et al.  Regulatory T Cells in Post-stroke Immune Homeostasis , 2016, Translational Stroke Research.

[19]  Shuxian Hu,et al.  Tregs Modulate Lymphocyte Proliferation, Activation, and Resident-Memory T-Cell Accumulation within the Brain during MCMV Infection , 2015, PloS one.

[20]  N. Shen,et al.  MiR-125a-5p Decreases the Sensitivity of Treg cells Toward IL-6-Mediated Conversion by Inhibiting IL-6R and STAT3 Expression , 2015, Scientific Reports.

[21]  T. Kupper,et al.  The emerging role of resident memory T cells in protective immunity and inflammatory disease , 2015, Nature Medicine.

[22]  Jieli Chen,et al.  Role of Regulatory T cell in Clinical Outcome of Traumatic Brain Injury , 2015, Chinese medical journal.

[23]  Ling Huang,et al.  Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T‐cell immunity against hepatitis B virus infection , 2015, Immunology.

[24]  K. Jin,et al.  Cerebral regulatory T cells restrain microglia/macrophage‐mediated inflammatory responses via IL‐10 , 2015, European journal of immunology.

[25]  S. Amor,et al.  Inflammation in neurodegenerative diseases – an update , 2014, Immunology.

[26]  F. Campos,et al.  Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia , 2014, Journal of cellular and molecular medicine.

[27]  D. Pardoll,et al.  Treg functional stability and its responsiveness to the microenvironment , 2014, Immunological reviews.

[28]  Hiroshi Takayanagi,et al.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis , 2013, Nature Medicine.

[29]  V. Boussiotis,et al.  IL-1β–Mediated Signals Preferentially Drive Conversion of Regulatory T Cells but Not Conventional T Cells into IL-17–Producing Cells , 2010, The Journal of Immunology.

[30]  J. Bluestone,et al.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.

[31]  R. Andreesen,et al.  Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation , 2009, European journal of immunology.

[32]  S. Zelenay,et al.  Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions , 2009, European journal of immunology.

[33]  W. Strober,et al.  Cutting Edge: Regulatory T Cells Induce CD4+CD25−Foxp3− T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-β , 2007, The Journal of Immunology.

[34]  A. Rudensky,et al.  Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 , 2007, Nature Immunology.

[35]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[36]  B. Li,et al.  Adipose Tissue-Resident Regulatory T Cells. , 2017, Advances in experimental medicine and biology.

[37]  Hongwei Wu,et al.  Regulatory T cells in the immunotherapy of melanoma , 2015, Tumor Biology.

[38]  Roger Williams,et al.  Modulation of the CD8 -T-Cell Response by CD4 CD25 Regulatory T Cells in Patients with Hepatitis B Virus Infection , 2005 .